U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938451) titled 'Relationship Between FGF19 Overexpression and Disease Prognosis' on March 27.

Brief Summary: A real-world study of FGF19 overexpression status and treatment outcome and prognosis in advanced hepatocellular carcinoma

Study Start Date: May 01

Study Type: OBSERVATIONAL

Condition: Hepatocellular Carcinoma (HCC)

Intervention: OTHER:

This is an observational study and does not involve an intervention

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing Tsinghua Chang Gung Hospital

Information provided by (Responsible Party): ZHAO YING, Beijing Tsinghua Chang Gung Hospital

Published by HT Digital Content Services with permis...